LIVE
Capital Markets
IPOs, M&A, private equity, venture capital and private debt: who raises, who invests, on what terms.
NewsCapital Markets✦ AIAnthropic IPO could make the average employee worth over $40 millionSEC filings and investors point to an average Anthropic employee worth over $40 million after the IPO on November 19. More than 400 staff could each hold over $100 million.CAPITAL MARKETS · UCAPITAL AIInvestor Match: find the right investors
Investors that fit your raise, from the platform and the web.
LATEST · CAPITAL MARKETS
BreakingCapital Markets✦ AIEU merger regulator clears UniCredit's bid for control of CommerzbankThe European Union's merger regulator has cleared UniCredit's plan to take over Germany's Commerzbank. The decision covers regulatory approval only and does not address the price of the offer.
Capital Markets✦ AICoal India unit Mahanadi Coalfields sets IPO price band of ₹129-₹136Mahanadi Coalfields, a Coal India subsidiary, opens its IPO on November 19 with a cap price of ₹136 and seeks a valuation of up to ₹90,001 crore. The offer is a sale of shares by Coal India.
Capital Markets✦ AIAnthropic IPO roadshow dominates the week as retail access excludes IndiaAnthropic's CEO pitched investors on Friday, days before the AI company's market debut. SoftBank sold Meesho shares worth Rs 1,885 crore, and Franklin Templeton is seeing stronger client inflows.
BreakingCapital Markets✦ AIBanks take Anthropic IPO to investors on roadshow as market uncertainty deepensInvestment banks have begun a roadshow to present an Anthropic initial public offering to investors. The deal could become the largest public offering ever, and it comes as market uncertainty deepens.
Capital Markets✦ AIAnthropic IPO draws sixfold demand as it seeks $64.4 billionDemand for shares in the Claude maker's offering is six times the amount available, with the company seeking $64.4 billion and targeting a $1.4 trillion valuation.
Capital Markets✦ AIBlackstone Life Sciences to cover $1.5 billion of Pfizer's berobenatide costsBlackstone Life Sciences will bear $1.5 billion of development costs for Pfizer's once-monthly weight-loss drug berobenatide through 2028, and will receive payments tied to milestones.
Capital Markets✦ AIAdani Group plans equity of up to $1.45 billion for $2.9 billion Evos dealAdani Group will fund its takeover of Evos, valued at $2.9 billion, with a mix of equity and debt. The equity part will be up to the equivalent of $1.45 billion.
Capital Markets✦ AIAnthropic sets IPO range at $70–$78 as Alibaba, Bajaj and RWE deals advanceAnthropic plans to offer 825 million shares at $70 to $78 each, while Alibaba confirms a Hong Kong filing for T-Head and Bajaj Finance prepares a 117 billion rupee share sale.Thinking about raising capital?
Discover the Deal Flow →Discover UCapital Capital Markets: Deal Flow, data room, target investors.
